Updated: September 2026
CAR T-cell therapy is offered in several European countries, including England, France, Germany, Spain and Italy. Depending on the country and the patient’s circumstances, treatment may be available through a national healthcare system or a private hospital.
For someone considering treatment abroad, price is only one part of the decision. It is also important to find out whether a suitable CAR-T therapy is available for their diagnosis, whether a center accepts international patients, and whether there is a waiting list.
What is the approximate cost of CAR-T in Europe?
As a broad guide, reported CAR-T prices in Europe can range from approximately €220,000 to €350,000 or more. This indicates the scale of the expense. It is not a standard price across Europe or a quote for a complete course of treatment. Prices and arrangements change, so patients should check current costs directly with the treating center.
An individual hospital estimate may include some related medical care. It is important to ask exactly what the quoted amount covers.
Why do prices differ between countries and patients?
Different CAR-T therapies are used for different types of lymphoma, leukemia and multiple myeloma. A treatment suitable for one patient may not be suitable for another.
Published prices can also describe different things. One figure may refer only to the CAR-T product, while another may include hospital services. The amount an international patient is quoted may differ from what an eligible resident pays through public healthcare.
What should an international patient ask before comparing options?
Once a specialist has reviewed the medical records, it is helpful to ask:
- Is a suitable CAR-T treatment available for my diagnosis and treatment history?
- Does the center currently accept international patients for this treatment?
- Is there a waiting list? What is the expected time from medical review to T-cell collection and then to infusion?
- What does the written cost estimate include?
- Could additional treatment, hospital care or other expenses be needed?
The timeline matters because a patient’s condition can change while waiting. Even when CAR-T is offered in a country, the treating center must confirm whether the appropriate treatment is available and when it could begin for that patient.
Comparing treatment in Europe and Israel
Israel is another option for patients considering CAR-T treatment abroad. Several Israeli hospitals have established CAR-T programs and extensive experience treating international patients. CAR-T treatment prices in Israel are generally lower than those quoted in Europe. Patients can request a medical review, a written cost estimate and information about the expected treatment timeline before deciding where to proceed.
Read reviews from CAR-T patients treated in Israel.
You can also explore our guide to CAR-T treatment costs in Israel.
Our team travelled to Strasbourg, France, to attend #CART25 – one of the most important conferences in European hematology. This event brought together the world's leading specialists to discuss the latest advancements in CAR-T therapy, a groundbreaking treatment transforming hematology and cancer care. Watch below.
Related reading
- CAR-T cell therapy in Israel
- CAR-T for leukemia and lymphoma in Israel
- CAR-T for multiple myeloma in Israel
- CAR-T for international patients
